Literature DB >> 17323834

Sundowning and circadian rhythm disorders in dementia.

S Klaffke1, J Staedt.   

Abstract

Sleep disorders and disruptive nocturnal behaviours are commonly reported in people with senile dementia and present both a significant clinical problem and a cause of increased stress for caregivers. Neuronal degeneration of cholinergic Nucleus basalis Meynert (NBM) neurons promote rest-activity disturbance and Sundowning in Alzheimer's disease. NBM neurons modulate the activity of the mainly cholinergic suprachiasmatic nucleus (SCN) and the induction of NONREM sleep. Sundowning might be explained as a syndrome occurring when arousal is to be processed while the neocortex is already turned "off" to (NONREM) sleep. The therapeutic measures should thus primarily be aimed at the stimulation of the circadian system and enforcing "external Zeitgebers". Pharmacologically, application of cholinergic enhancers i.e. cholinesterase inhibitors and melatonin supports and should stabilize the weakened structures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17323834

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  15 in total

1.  Effects of aging on circadian patterns of gene expression in the human prefrontal cortex.

Authors:  Cho-Yi Chen; Ryan W Logan; Tianzhou Ma; David A Lewis; George C Tseng; Etienne Sibille; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

Review 2.  Chronobiological disorders: current and prevalent conditions.

Authors:  Lia R A Bittencourt; Rogerio Santos-Silva; Marco T de Mello; Monica L Andersen; Sergio Tufik
Journal:  J Occup Rehabil       Date:  2010-03

3.  Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.

Authors:  Tracy A Bedrosian; Kamillya L Herring; Zachary M Weil; Randy J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

4.  Sustained high body temperature exacerbates cognitive function and Alzheimer's disease-related pathologies.

Authors:  Cha-Gyun Jung; Reiko Kato; Chunyu Zhou; Mona Abdelhamid; Esraa Ibrahim A Shaaban; Hitoshi Yamashita; Makoto Michikawa
Journal:  Sci Rep       Date:  2022-07-18       Impact factor: 4.996

5.  Impaired satiation and increased feeding behaviour in the triple-transgenic Alzheimer's disease mouse model.

Authors:  Adedolapo Adebakin; Jenna Bradley; Sarah Gümüsgöz; Elizabeth J Waters; Catherine B Lawrence
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

6.  Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

Authors:  Venkatramanujam Srinivasan; Charanjit Kaur; Seithikurippu Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2010-12-08

7.  Sundown syndrome in persons with dementia: an update.

Authors:  Nina Khachiyants; David Trinkle; Sang Joon Son; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2011-11-04       Impact factor: 2.505

Review 8.  Biological clocks and the practice of psychiatry.

Authors:  Pierre Schulz
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

9.  Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.

Authors:  Elysse M Knight; Timothy M Brown; Sarah Gümüsgöz; Jennifer C M Smith; Elizabeth J Waters; Stuart M Allan; Catherine B Lawrence
Journal:  Dis Model Mech       Date:  2012-08-03       Impact factor: 5.758

10.  β-amyloid infusion into lateral ventricle alters behavioral thermoregulation and attenuates acquired heat tolerance in rats.

Authors:  Kentaro Matsuzaki; Masanori Katakura; Naotoshi Sugimoto; Toshiko Hara; Michio Hashimoto; Osamu Shido
Journal:  Temperature (Austin)       Date:  2015-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.